Catalyst Pharmaceutical Partners Announces Second Quarter 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Catyalyst Pharmaceutical Partners (CPRX) Tops Q2 EPS by 2c
August 14, 2014 8:04 AM EDTCatyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
... More